{"title":"Products","description":null,"products":[{"product_id":"20mg-retatrutide","title":"RETATRUTIDE 20mg","description":"\u003cp data-end=\"355\" data-start=\"0\"\u003e\u003cstrong data-end=\"16\" data-start=\"0\"\u003eRetatrutide:\u003cmeta charset=\"utf-8\"\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003ch2\u003eProduct Specifications\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eName:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eRetatrutide\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSynonyms:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eLY3437943\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePurity:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003e≥99% (independent third-party HPLC\/MS)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMolecular Formula:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eC₂₂₁H₃₄₂N₄₆O₆₈\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMolecular Weight:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003e~4,731.33 g\/mol\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAdditives:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eNone (mannitol-free)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eIntended use:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eIn-vitro\/ex-vivo research only\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003ch2\u003eStorage \u0026amp; Stability\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eUnreconstituted:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eStore dry and light-protected\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAfter reconstitution:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003e2–8 °C; aliquot to reduce freeze-thaw cycles\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eShelf life:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003e4 years\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-end=\"505\" data-start=\"357\"\u003e\u003cstrong data-end=\"380\" data-start=\"357\"\u003eMechanism of Action:\u003c\/strong\u003e\u003cbr data-end=\"383\" data-start=\"380\"\u003eRetatrutide is a \u003cstrong data-end=\"427\" data-start=\"400\"\u003etriple-receptor agonist\u003c\/strong\u003e that activates three hormone receptors involved in metabolism and appetite:\u003c\/p\u003e\n\u003cul data-end=\"855\" data-start=\"506\"\u003e\n\u003cli data-end=\"545\" data-start=\"506\"\u003e\n\u003cp data-end=\"545\" data-start=\"508\"\u003e\u003cstrong data-end=\"543\" data-start=\"508\"\u003eGLP-1 (glucagon-like peptide-1)\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"604\" data-start=\"546\"\u003e\n\u003cp data-end=\"604\" data-start=\"548\"\u003e\u003cstrong data-end=\"602\" data-start=\"548\"\u003eGIP (glucose-dependent insulinotropic polypeptide)\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"855\" data-start=\"605\"\u003e\n\u003cp data-end=\"855\" data-start=\"607\"\u003e\u003cstrong data-end=\"619\" data-start=\"607\"\u003eGlucagon\u003c\/strong\u003e\u003cbr data-end=\"622\" data-start=\"619\"\u003eThis “triple” activity aims to reduce appetite, regulate blood sugar, increase energy expenditure, and enhance fat burning more effectively than drugs targeting only one or two of these pathways.\u003cspan data-state=\"closed\" class=\"\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-end=\"879\" data-start=\"857\"\u003e\u003cstrong data-end=\"877\" data-start=\"857\"\u003eClinical Effects\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul data-end=\"1579\" data-start=\"880\"\u003e\n\u003cli data-end=\"1093\" data-start=\"880\"\u003e\n\u003cp data-end=\"1093\" data-start=\"882\"\u003eIn late-stage trials, retatrutide has produced substantial weight loss — up to about \u003cstrong data-end=\"1018\" data-start=\"967\"\u003e28.7 % of body weight on average over ~68 weeks\u003c\/strong\u003e, with many achieving 30 % or more. \u003cspan data-state=\"closed\" class=\"\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1259\" data-start=\"1094\"\u003e\n\u003cp data-end=\"1259\" data-start=\"1096\"\u003eSignificant improvements in joint-pain and physical function have also been observed in obese patients with osteoarthritis. \u003cspan data-state=\"closed\" class=\"\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1380\" data-start=\"1260\"\u003e\n\u003cp data-end=\"1380\" data-start=\"1262\"\u003eEarlier studies showed weight reductions of roughly \u003cstrong data-end=\"1339\" data-start=\"1314\"\u003e22–24 % over 48 weeks\u003c\/strong\u003e. \u003cspan data-state=\"closed\" class=\"\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1579\" data-start=\"1381\"\u003e\n\u003cp data-end=\"1579\" data-start=\"1383\"\u003eThe drug also shows effects on \u003cstrong data-end=\"1461\" data-start=\"1414\"\u003eblood glucose control and metabolic markers\u003c\/strong\u003e relevant to type 2 diabetes and fatty liver disease, though research continues. \u003cspan data-state=\"closed\" class=\"\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-end=\"1730\" data-start=\"1581\"\u003e\u003cstrong data-end=\"1599\" data-start=\"1581\"\u003eAdministration\u003c\/strong\u003e\u003cbr data-end=\"1602\" data-start=\"1599\"\u003eRetatrutide is delivered by a \u003cstrong data-end=\"1670\" data-start=\"1632\"\u003eonce-weekly subcutaneous injection\u003c\/strong\u003e in clinical settings. \u003cspan data-state=\"closed\" class=\"\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp data-end=\"2157\" data-start=\"1732\"\u003e\u003cstrong data-end=\"1759\" data-start=\"1732\"\u003eSide Effects and Safety\u003c\/strong\u003e\u003cbr data-end=\"1762\" data-start=\"1759\"\u003eCommon side effects reported in trials are primarily \u003cstrong data-end=\"1835\" data-start=\"1815\"\u003egastrointestinal\u003c\/strong\u003e, including nausea, vomiting, diarrhea, and constipation. These effects are dose-related and often mild to moderate, and some participants discontinue therapy due to intolerance. \u003cbr data-end=\"2054\" data-start=\"2051\"\u003eOther observed effects include transient increases in heart rate. \u003cspan data-state=\"closed\" class=\"\"\u003e\u003c\/span\u003e\u003cstrong data-end=\"2186\" data-start=\"2159\"\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp data-end=\"2531\" data-start=\"2499\"\u003e\u003cstrong data-end=\"2529\" data-start=\"2499\"\u003ePotential Uses Under Study:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul data-end=\"2856\" data-start=\"2532\"\u003e\n\u003cli data-end=\"2586\" data-start=\"2532\"\u003e\n\u003cp data-end=\"2586\" data-start=\"2534\"\u003e\u003cstrong data-end=\"2556\" data-start=\"2534\"\u003eObesity management\u003c\/strong\u003e and significant weight loss\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2650\" data-start=\"2587\"\u003e\n\u003cp data-end=\"2650\" data-start=\"2589\"\u003e\u003cstrong data-end=\"2618\" data-start=\"2589\"\u003eType 2 diabetes treatment\u003c\/strong\u003e via improved glycemic control\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2856\" data-start=\"2651\"\u003e\n\u003cp data-end=\"2856\" data-start=\"2653\"\u003e\u003cstrong data-end=\"2703\" data-start=\"2653\"\u003eMetabolic dysfunction–associated liver disease\u003c\/strong\u003e through reduction in liver fat\u003cbr data-end=\"2737\" data-start=\"2734\"\u003eResearch continues to confirm long-term efficacy and safety across populations.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"Aureon Bioscience","offers":[{"title":"Default Title","offer_id":46296699371678,"sku":null,"price":350.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0747\/1543\/1070\/files\/RETATRUTIDE.jpg?v=1776914703"},{"product_id":"tesamorelin-10mg","title":"TESAMORELIN 20mg","description":"\u003cp data-start=\"0\" data-end=\"243\"\u003e\u003cstrong\u003eTesamorelin\u003c\/strong\u003e is a synthetic research peptide and stabilized analog of growth hormone–releasing hormone (GHRH) designed to selectively activate the GHRH receptor and stimulate endogenous growth hormone secretion in experimental models. Preclinical and clinical research has focused on its role in modulating somatotropic signaling, lipid metabolism, and visceral adipose regulation through cAMP-dependent pituitary pathways. Tesamorelin is utilized in research investigating hypothalamic–pituitary axis dynamics, metabolic signaling, neuroendocrine regulation, and growth hormone–mediated tissue effects. \u003c\/p\u003e\n\u003cp data-start=\"245\" data-end=\"264\"\u003eHere’s a breakdown:\u003c\/p\u003e\n\u003ch3 data-start=\"271\" data-end=\"294\"\u003e\u003cstrong data-start=\"278\" data-end=\"294\"\u003eWhat It Does\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-start=\"295\" data-end=\"562\"\u003eTesamorelin binds to GHRH receptors in the pituitary gland, stimulating \u003cstrong data-start=\"367\" data-end=\"395\"\u003egrowth hormone secretion\u003c\/strong\u003e. This, in turn, increases \u003cstrong data-start=\"422\" data-end=\"462\"\u003einsulin-like growth factor 1 (IGF-1)\u003c\/strong\u003e levels in the blood — the main mediator of GH’s anabolic (muscle-building and fat-burning) effects.\u003c\/p\u003e\n\u003ch3 data-start=\"569\" data-end=\"591\"\u003e\u003cstrong data-start=\"576\" data-end=\"591\"\u003eMedical Use\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-start=\"592\" data-end=\"662\"\u003eTesamorelin is \u003cstrong data-start=\"607\" data-end=\"623\"\u003eFDA-approved\u003c\/strong\u003e under the brand name \u003cstrong data-start=\"645\" data-end=\"657\"\u003eEgrifta®\u003c\/strong\u003e for:\u003c\/p\u003e\n\u003cul data-start=\"663\" data-end=\"780\"\u003e\n\u003cli data-start=\"663\" data-end=\"780\"\u003e\n\u003cp data-start=\"665\" data-end=\"780\"\u003e\u003cstrong data-start=\"665\" data-end=\"730\"\u003eReducing excess abdominal fat in HIV-associated lipodystrophy\u003c\/strong\u003e (fat accumulation due to antiretroviral therapy).\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3 data-start=\"787\" data-end=\"823\"\u003e\u003cstrong data-start=\"794\" data-end=\"823\"\u003eOff-Label \/ Research Uses\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-start=\"824\" data-end=\"889\"\u003eIn the performance and anti-aging world, it’s often explored for:\u003c\/p\u003e\n\u003cul data-start=\"890\" data-end=\"1121\"\u003e\n\u003cli data-start=\"890\" data-end=\"934\"\u003e\n\u003cp data-start=\"892\" data-end=\"934\"\u003e\u003cstrong data-start=\"892\" data-end=\"934\"\u003eReducing visceral and subcutaneous fat\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"935\" data-end=\"975\"\u003e\n\u003cp data-start=\"937\" data-end=\"975\"\u003e\u003cstrong data-start=\"937\" data-end=\"975\"\u003eImproving muscle tone and recovery\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"976\" data-end=\"1020\"\u003e\n\u003cp data-start=\"978\" data-end=\"1020\"\u003e\u003cstrong data-start=\"978\" data-end=\"1020\"\u003eEnhancing sleep and cognitive function\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"1021\" data-end=\"1070\"\u003e\n\u003cp data-start=\"1023\" data-end=\"1070\"\u003e\u003cstrong data-start=\"1023\" data-end=\"1070\"\u003eImproving skin elasticity and tissue repair\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"1071\" data-end=\"1121\"\u003e\n\u003cp data-start=\"1073\" data-end=\"1121\"\u003e\u003cstrong data-start=\"1073\" data-end=\"1121\"\u003eSupporting natural GH levels in older adults\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3 data-start=\"1128\" data-end=\"1153\"\u003e\u003cstrong data-start=\"1135\" data-end=\"1153\"\u003eAdministration\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cul data-start=\"1154\" data-end=\"1340\"\u003e\n\u003cli data-start=\"1154\" data-end=\"1220\"\u003e\n\u003cp data-start=\"1156\" data-end=\"1220\"\u003eUsually \u003cstrong data-start=\"1164\" data-end=\"1191\"\u003einjected subcutaneously\u003c\/strong\u003e (under the skin) once daily.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"1221\" data-end=\"1340\"\u003e\n\u003cp data-start=\"1223\" data-end=\"1340\"\u003eCommon research doses: \u003cstrong data-start=\"1246\" data-end=\"1264\"\u003e1–2 mg per day\u003c\/strong\u003e, often before bedtime on an empty stomach to align with natural GH release.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3 data-start=\"1347\" data-end=\"1380\"\u003e\u003cstrong data-start=\"1354\" data-end=\"1380\"\u003ePotential Side Effects\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cul data-start=\"1381\" data-end=\"1617\"\u003e\n\u003cli data-start=\"1381\" data-end=\"1433\"\u003e\n\u003cp data-start=\"1383\" data-end=\"1433\"\u003eTemporary \u003cstrong data-start=\"1393\" data-end=\"1433\"\u003einjection site redness or irritation\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"1434\" data-end=\"1512\"\u003e\n\u003cp data-start=\"1436\" data-end=\"1512\"\u003e\u003cstrong data-start=\"1436\" data-end=\"1455\"\u003eWater retention\u003c\/strong\u003e, mild \u003cstrong data-start=\"1462\" data-end=\"1476\"\u003ejoint pain\u003c\/strong\u003e, or \u003cstrong data-start=\"1481\" data-end=\"1512\"\u003ecarpal tunnel–like symptoms\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"1513\" data-end=\"1571\"\u003e\n\u003cp data-start=\"1515\" data-end=\"1571\"\u003e\u003cstrong data-start=\"1515\" data-end=\"1537\"\u003eInsulin resistance\u003c\/strong\u003e or mild \u003cstrong data-start=\"1546\" data-end=\"1571\"\u003eblood sugar elevation\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"1572\" data-end=\"1617\"\u003e\n\u003cp data-start=\"1574\" data-end=\"1617\"\u003e\u003cstrong data-start=\"1574\" data-end=\"1584\"\u003eNausea\u003c\/strong\u003e or \u003cstrong data-start=\"1588\" data-end=\"1617\"\u003etingling in hands\/fingers\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3 data-start=\"1624\" data-end=\"1652\"\u003e\u003cstrong data-start=\"1631\" data-end=\"1652\"\u003eHalf-Life \u0026amp; Onset\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cul data-start=\"1653\" data-end=\"1789\"\u003e\n\u003cli data-start=\"1653\" data-end=\"1680\"\u003e\n\u003cp data-start=\"1655\" data-end=\"1680\"\u003e\u003cstrong data-start=\"1655\" data-end=\"1669\"\u003eHalf-life:\u003c\/strong\u003e ~2 hours\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"1681\" data-end=\"1738\"\u003e\n\u003cp data-start=\"1683\" data-end=\"1738\"\u003e\u003cstrong data-start=\"1683\" data-end=\"1705\"\u003eGH elevation peaks\u003c\/strong\u003e about 1–2 hours post-injection\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"1739\" data-end=\"1789\"\u003e\n\u003cp data-start=\"1741\" data-end=\"1789\"\u003e\u003cstrong data-start=\"1741\" data-end=\"1759\"\u003eIGF-1 increase\u003c\/strong\u003e is gradual over days to weeks\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"Aureon Bioscience","offers":[{"title":"Default Title","offer_id":46296702779550,"sku":null,"price":325.0,"currency_code":"USD","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0747\/1543\/1070\/files\/TESAMORELIN.jpg?v=1776914703"},{"product_id":"bpc-157-tb-500-ghk-cu-70mg","title":"KLOW- BPC-157 + TB-500 + Ghk-Cu + KPV 80mg","description":"\u003cp\u003eThe\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003eKlow Blend\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003ecombines four research peptides,\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003eBPC-157\u003c\/strong\u003e,\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003eTB-500\u003c\/strong\u003e,\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003eKPV\u003c\/strong\u003e, and\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003eGHK-Cu\u003c\/strong\u003e, formulated for studies on cellular repair, immune modulation, and extracellular matrix regulation. BPC-157 is a 15 amino acid gastric peptide fragment that modulates nitric oxide and growth factor pathways. TB-500, a segment of Thymosin Beta-4, regulates actin polymerization and tissue remodeling. KPV, derived from the C-terminal region of alpha-melanocyte-stimulating hormone, modulates NF-κB and cytokine signaling. GHK-Cu, a copper(II)-complexed tripeptide, influences metalloprotein activity and redox balance. Together, these peptides are used in research examining regeneration, inflammation, and peptide–metal interaction mechanisms.\u003c\/p\u003e\n\u003cp\u003eFor research use only. Not for human consumption.\u003c\/p\u003e\n\u003cp\u003e\u003cbr\u003e\u003c\/p\u003e","brand":"Aureon Bioscience","offers":[{"title":"Default Title","offer_id":46296703565982,"sku":null,"price":375.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0747\/1543\/1070\/files\/KLOW.jpg?v=1776914703"},{"product_id":"test-product-sku-1","title":"NAD+ 1000mg","description":"\u003cp\u003e\u003cstrong\u003eNAD⁺ (nicotinamide adenine dinucleotide)\u003cspan\u003e \u003c\/span\u003e\u003c\/strong\u003eis an essential cellular coenzyme involved in redox metabolism and energy production across all living systems. It functions as a critical electron carrier by cycling between its oxidized (NAD⁺) and reduced (NADH) states, enabling mitochondrial oxidative phosphorylation and glycolytic energy transfer in experimental models. Beyond its metabolic role, NAD⁺ serves as a required substrate for sirtuins and poly(ADP-ribose) polymerases (PARPs), enzymes involved in DNA repair, gene expression regulation, and cellular stress responses. Preclinical research utilizes NAD⁺ to investigate mitochondrial homeostasis, muscle metabolism, neuroprotection, and molecular mechanisms associated with aging and cellular resilience. \u003c\/p\u003e\n\u003cp\u003eFor research use only. Not for human consumption. \u003c\/p\u003e\n\u003cp data-start=\"157\" data-end=\"412\"\u003e\u003cstrong data-start=\"157\" data-end=\"177\"\u003eProduct Overview\u003c\/strong\u003e\u003cbr data-start=\"177\" data-end=\"180\"\u003eThis peptide is produced in a controlled laboratory environment using validated synthesis and purification protocols to ensure high purity and consistency. Each batch is carefully processed to meet strict internal quality standards.\u003c\/p\u003e\n\u003cp data-start=\"414\" data-end=\"648\"\u003e\u003cstrong data-start=\"414\" data-end=\"435\"\u003eQuality \u0026amp; Testing\u003c\/strong\u003e\u003cbr data-start=\"435\" data-end=\"438\"\u003eManufactured under sterile conditions and independently tested to verify purity, composition, and integrity. Analytical methods may include HPLC and mass spectrometry to confirm specifications prior to release.\u003c\/p\u003e\n\u003cp data-start=\"650\" data-end=\"810\"\u003e\u003cstrong data-start=\"650\" data-end=\"666\"\u003eIntended Use\u003c\/strong\u003e\u003cbr data-start=\"666\" data-end=\"669\"\u003eFor \u003cstrong data-start=\"673\" data-end=\"709\"\u003eresearch and laboratory use only\u003c\/strong\u003e. Not intended for human or veterinary use. Not for diagnostic, therapeutic, or consumptive purposes.\u003c\/p\u003e\n\u003cp data-start=\"812\" data-end=\"948\"\u003e\u003cstrong data-start=\"812\" data-end=\"834\"\u003eHandling \u0026amp; Storage\u003c\/strong\u003e\u003cbr data-start=\"834\" data-end=\"837\"\u003eStore in a cool, dry environment away from direct light. Handle using appropriate laboratory safety procedures.\u003c\/p\u003e\n\u003cp data-start=\"950\" data-end=\"968\"\u003e \u003c\/p\u003e","brand":"Aureon Bioscience","offers":[{"title":"Default Title","offer_id":46486717235358,"sku":null,"price":300.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0747\/1543\/1070\/files\/NAD.jpg?v=1776914703"},{"product_id":"test-product-sku-4","title":"MELANOTAN II (MT2 10mg)","description":"\u003cp\u003e\u003cstrong\u003eMelanotan 2\u003c\/strong\u003e is a synthetic cyclic heptapeptide (Ac-Nle-c[Asp-His-D-Phe-Arg-Trp-Lys]-NH₂) that functions as a potent nonselective melanocortin receptor agonist. It is employed in receptor binding and signal transduction studies exploring MC1R–MC5R-mediated cAMP activation and GPCR desensitization mechanisms. MT-II provides a research model for peptide–receptor pharmacology and neuroendocrine signaling dynamics.\u003c\/p\u003e\n\u003cp\u003eFor research use only. Not for human consumption.\u003c\/p\u003e","brand":"Aureon Bioscience","offers":[{"title":"Default Title","offer_id":46486730604702,"sku":null,"price":65.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0747\/1543\/1070\/files\/MT2.jpg?v=1776914701"},{"product_id":"test-product-sku-5","title":"PT 141 10mg","description":"\u003cp\u003e\u003cstrong\u003ePT-141\u003cspan\u003e \u003c\/span\u003e\u003c\/strong\u003eis a synthetic melanocortin receptor agonist structurally derived from the analog Melanotan II. It binds selectively to MC3R and MC4R, modulating neuropeptide signaling pathways involved in hypothalamic control mechanisms. PT-141 is commonly employed in research focusing on GPCR activation, neuronal signaling, and neuroendocrine modulation.\u003c\/p\u003e\n\u003cp\u003eFor research use only. Not for human consumption.\u003c\/p\u003e","brand":"Aureon Bioscience","offers":[{"title":"Default Title","offer_id":46486730768542,"sku":null,"price":65.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0747\/1543\/1070\/files\/PT141.jpg?v=1776914703"},{"product_id":"test-product-sku-6","title":"BACTERIOSTATIC WATER 10ml","description":"\u003cp\u003e\u003cmeta charset=\"utf-8\"\u003e\u003cstrong data-start=\"0\" data-end=\"37\" data-is-only-node=\"\"\u003eBacteriostatic water (bac water):\u003c\/strong\u003e\u003cbr data-start=\"37\" data-end=\"40\"\u003eSterile water for injection containing \u003cstrong data-start=\"79\" data-end=\"102\"\u003e0.9% benzyl alcohol\u003c\/strong\u003e as a preservative, used to dilute or reconstitute parenteral medications and allow multiple-dose use by inhibiting bacterial growth.\u003c\/p\u003e","brand":"Aureon Bioscience","offers":[{"title":"Default Title","offer_id":46486855516318,"sku":null,"price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0747\/1543\/1070\/files\/BACTERIOSTATIC-WATER.jpg?v=1776914701"},{"product_id":"test-product-sku-7","title":"MOTS-C 20mg","description":"\u003cp\u003e\u003cstrong\u003eMOTS-c\u003c\/strong\u003e is a research peptide derived from mitochondria and composed of 16 amino acids (Met-Arg-Trp-Gln-Glu-Met-Gly-Tyr-Ile-Phe-Tyr-Pro-Arg-Lys-Leu-Arg). Encoded within the mitochondrial 12S rRNA gene, it regulates cellular metabolism through AMPK activation and mitochondrial homeostasis in preclinical studies. MOTS-c is widely used in metabolic and aging research investigating mitochondrial signaling, stress adaptation, and energy regulation mechanisms.\u003c\/p\u003e\n\u003cp\u003eFor research use only. Not for human consumption.\u003c\/p\u003e","brand":"Aureon Bioscience","offers":[{"title":"Default Title","offer_id":46486857482398,"sku":null,"price":185.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0747\/1543\/1070\/files\/MOTS-C.jpg?v=1776914703"},{"product_id":"aod9604","title":"AOD9604","description":"\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003e\u003cstrong\u003eOverview\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003eAOD9604 is a synthetic peptide fragment derived from the C-terminal domain of human growth hormone (hGH), comprising amino acid residues 176–191 with a tyrosine substitution at the N-terminus. Originally developed by Metabolic Pharmaceuticals as a potential anti-obesity agent, it was designed to replicate the lipolytic properties of hGH without activating the growth hormone receptor or elevating IGF-1 levels.\u003c\/p\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003e\u003cstrong\u003eMechanism of Action\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003eAOD9604 is proposed to stimulate lipolysis and inhibit lipogenesis through mechanisms involving upregulation of beta-3 adrenergic receptor (β3-AR) expression in adipocytes, modulation of hormone-sensitive lipase (HSL), and inhibition of acetyl-CoA carboxylase. Unlike intact hGH, it does not meaningfully affect insulin sensitivity or glucose metabolism at research doses.\u003c\/p\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003e\u003cstrong\u003eResearch and Off-Label Applications\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003eAOD9604 has been investigated for reduction of visceral and subcutaneous adipose tissue, fat oxidation and energy expenditure, cartilage and tissue repair, and as a potential adjunct in metabolic syndrome research. Human clinical trials have produced mixed results, with one 12-week randomized trial reporting approximately 1.8 kg greater fat loss versus placebo. Animal models have demonstrated more pronounced lipolytic effects.\u003c\/p\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003e\u003cstrong\u003eAdministration\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003eTypically administered via subcutaneous injection. Research protocols commonly utilize doses of 250–500 mcg per day, often in the morning to align with natural fat metabolism cycles. Higher doses have not demonstrated significantly greater outcomes in clinical data.\u003c\/p\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003e\u003cstrong\u003eRegulatory Status\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003eAOD9604 is not FDA-approved for any indication. It is classified as a prescription-only substance by Australia's Therapeutic Goods Administration (TGA) and is prohibited in competitive sport under WADA regulations. Clinical development was halted in 2007.\u003c\/p\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003e\u003cstrong\u003ePotential Adverse Effects\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003eGenerally well tolerated in available research. Reported effects include mild injection site reactions. No significant impact on insulin sensitivity has been reported at research doses.\u003c\/p\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003e\u003cstrong\u003ePharmacokinetics\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003ePlasma half-life is approximately 4 minutes following intravenous administration; oral forms demonstrate slower absorption kinetics. Sequential N-terminal amino acid truncation is the primary degradation pathway.\u003c\/p\u003e","brand":"Aureon Bioscience","offers":[{"title":"Default Title","offer_id":46655973032094,"sku":null,"price":100.0,"currency_code":"USD","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0747\/1543\/1070\/files\/AOD9604.jpg?v=1776914702"},{"product_id":"igf-1lr3","title":"IGF-1LR3","description":"\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003e\u003cstrong\u003eOverview\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003eIGF-1 LR3 (Long Arginine 3-Insulin-like Growth Factor 1) is a synthetic, 83-amino acid analog of human IGF-1, modified with an arginine substitution at position 3 and a 13-amino acid N-terminal extension. These structural modifications dramatically reduce its binding affinity to IGF-binding proteins (IGFBPs), particularly IGFBP-3, increasing its bioavailability and extending its half-life. IGF-1 LR3 is approximately three times more potent than native IGF-1 and is used in research investigating cellular growth, anabolic signaling, metabolic regulation, and tissue regeneration.\u003c\/p\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003e\u003cstrong\u003eMechanism of Action\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003eIGF-1 LR3 binds to and activates the IGF-1 receptor (IGF-1R), triggering downstream signaling cascades including the PI3K\/Akt\/mTOR pathway, which promotes protein synthesis and cell survival, and the MAPK pathway, which stimulates cellular proliferation and differentiation. By evading rapid binding to IGFBPs, it remains biologically active in circulation significantly longer than endogenous IGF-1.\u003c\/p\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003e\u003cstrong\u003eResearch and Off-Label Applications\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003eInvestigated for skeletal muscle growth, repair, and satellite cell activation, fat metabolism and body recomposition, tissue regeneration and recovery, glucose metabolism and insulin sensitivity, and neurological and anti-aging research.\u003c\/p\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003e\u003cstrong\u003eAdministration\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003eAdministered via subcutaneous injection. Research cycles typically range from 4–6 weeks. IGF-1 LR3 is not FDA-approved for any indication.\u003c\/p\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003e\u003cstrong\u003ePotential Adverse Effects\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003ePotential concerns include effects on glucose metabolism and insulin sensitivity, risk of cellular proliferation in individuals with existing malignancies, and joint or soft tissue swelling. Long-term safety data in humans is limited.\u003c\/p\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003e\u003cstrong\u003ePharmacokinetics\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003eHalf-life: approximately 20–30 hours, compared to 12–15 hours for native IGF-1.\u003c\/p\u003e","brand":"Aureon Bioscience","offers":[{"title":"Default Title","offer_id":46655973228702,"sku":null,"price":120.0,"currency_code":"USD","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0747\/1543\/1070\/files\/IGF-1LR3.jpg?v=1776914701"},{"product_id":"ghk-cu","title":"GHK-CU 100mg","description":"\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003e\u003cstrong\u003eOverview\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003eGHK-Cu (glycyl-L-histidyl-L-lysine–copper) is a naturally occurring copper-peptide complex first isolated from human plasma albumin in 1973. It is found endogenously in plasma, saliva, and urine, with concentrations declining from approximately 200 ng\/mL at age 20 to 80 ng\/mL by age 60. This age-related decline is associated with reduced regenerative capacity. GHK-Cu is among the most extensively researched peptides in regenerative medicine and cosmeceutical science.\u003c\/p\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003e\u003cstrong\u003eMechanism of Action\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003eGHK-Cu functions as both a signaling peptide and a copper-carrying complex. It stimulates collagen, elastin, and glycosaminoglycan synthesis in dermal fibroblasts, modulates matrix metalloproteinase (MMP) activity to support extracellular matrix remodeling, and promotes angiogenesis via vascular endothelial growth factor (VEGF) signaling. Gene expression studies indicate that GHK influences upward of 30% of human genes, including those related to tissue repair, anti-inflammatory responses, antioxidant defense, and nerve regeneration.\u003c\/p\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003e\u003cstrong\u003eResearch and Off-Label Applications\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003eWound healing and tissue repair, skin anti-aging and collagen stimulation, hair follicle health and scalp circulation, anti-inflammatory and antioxidant activity, and emerging investigation into lung fibrosis, gastrointestinal conditions, and neuroprotection.\u003c\/p\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003e\u003cstrong\u003eAdministration\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003eAvailable as both a topical cosmeceutical ingredient (INCI name: Copper Tripeptide-1) and as a prescription injectable. Topical formulations typically show measurable results within 6–8 weeks. Injectable forms may demonstrate changes within 2–4 weeks.\u003c\/p\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003e\u003cstrong\u003ePotential Adverse Effects\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003eTopical use is generally well tolerated. Injectable use may cause mild injection site reactions. Serious adverse events are rare at cosmetic concentrations. Long-term systemic safety data remains under investigation.\u003c\/p\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003e \u003c\/p\u003e","brand":"Aureon Bioscience","offers":[{"title":"Default Title","offer_id":46655973261470,"sku":null,"price":120.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0747\/1543\/1070\/files\/GHK-CU.jpg?v=1776914703"},{"product_id":"5-amino-1mq","title":"5-AMINO-1MQ - 50mg","description":"\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003e\u003cstrong\u003eOverview\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003e5-Amino-1MQ (5-amino-1-methylquinolinium) is a synthetic, cell-permeable small molecule investigated as a selective inhibitor of nicotinamide N-methyltransferase (NNMT), an enzyme involved in the methylation of nicotinamide and regulation of NAD+ availability. It is classified as a research compound and is not FDA-approved. Current evidence is primarily derived from preclinical cell-based and animal studies.\u003c\/p\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003e\u003cstrong\u003eMechanism of Action\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003eBy inhibiting NNMT, 5-Amino-1MQ preserves intracellular NAD+ levels by preventing the conversion of nicotinamide to 1-methylnicotinamide (1-MNA). Elevated NAD+ availability activates SIRT1 (sirtuin-1) pathways associated with mitochondrial biogenesis, fat oxidation, and metabolic flexibility. Simultaneously, higher S-adenosylmethionine (SAM) availability supports methylation-dependent gene expression and epigenetic regulation.\u003c\/p\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003e\u003cstrong\u003eResearch and Off-Label Applications\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003eInvestigated for reduction of visceral and white adipose tissue, improved insulin sensitivity and glucose metabolism, preservation of lean muscle mass, enhancement of mitochondrial function and energy expenditure, and muscle strength and recovery support. A 2024 preclinical study published in Scientific Reports demonstrated additive improvements in grip strength and exercise endurance when combined with resistance training in aged mice.\u003c\/p\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003e\u003cstrong\u003eAdministration\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003eResearch protocols use oral dosing of approximately 50 mg taken 1–3 times daily, or subcutaneous injection. Common research cycles are approximately 2 months on, followed by a 1-month washout period.\u003c\/p\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003e\u003cstrong\u003ePotential Adverse Effects\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003eGenerally well tolerated in available studies. Reported mild effects include nausea, fatigue, and dizziness. Long-term human safety data is not established.\u003c\/p\u003e","brand":"Aureon Bioscience","offers":[{"title":"Default Title","offer_id":46655973425310,"sku":null,"price":225.0,"currency_code":"USD","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0747\/1543\/1070\/files\/5-AMINO.jpg?v=1776914703"},{"product_id":"snap-9","title":"SNAP-8","description":"\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003e\u003cstrong\u003eOverview\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003eSNAP-8, also known as Acetyl Glutamyl Heptapeptide-1 or Acetyl Octapeptide-3, is a synthetic octapeptide developed as a topical neuromodulatory ingredient and elongated analog of Argireline (Acetyl Hexapeptide-3). It is designed to reduce the appearance of dynamic facial expression lines through competitive inhibition of the SNARE complex. It is not intended for injection and is used primarily in topical cosmeceutical formulations.\u003c\/p\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003e\u003cstrong\u003eMechanism of Action\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003eSNAP-8 mimics the N-terminal end of SNAP-25, a key component of the SNARE (SNapREceptor) protein complex responsible for synaptic vesicle fusion and neurotransmitter release. By competing with SNAP-25 for a position in the SNARE complex, SNAP-8 partially destabilizes the complex, reducing acetylcholine release at the neuromuscular junction and attenuating the intensity of facial muscle contractions. This mechanism is pharmacologically analogous to botulinum toxin but operates via competitive inhibition rather than enzymatic cleavage.\u003c\/p\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003e\u003cstrong\u003eResearch and Clinical Data\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003eManufacturer-funded in vivo studies using 10% SNAP-8 in topical formulations demonstrated up to 63% reduction in wrinkle depth around the eye area after 28 days of twice-daily application. Independent research reports more conservative improvements of 10–20%. SNAP-8 is reported to be approximately 30% more active than Argireline in both in vitro and in vivo testing.\u003c\/p\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003e\u003cstrong\u003eAdministration\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003eApplied topically at concentrations of 3–10% in serums, creams, and other emulsion formulations. Twice-daily application is recommended; consistent use over 4–8 weeks is required to observe measurable improvements. Effects are not permanent and diminish upon discontinuation.\u003c\/p\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003e\u003cstrong\u003ePotential Adverse Effects\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003eConsidered generally safe and well tolerated in clinical testing over 12 weeks. No significant adverse events reported at recommended concentrations. Some formulations may cause mild irritation in sensitive skin types.\u003c\/p\u003e","brand":"Aureon Bioscience","offers":[{"title":"Default Title","offer_id":46655975653534,"sku":null,"price":70.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0747\/1543\/1070\/files\/SNAP-8.jpg?v=1776914702"},{"product_id":"slu-pp-322","title":"SLU-PP-322 5mg","description":"\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003e\u003cstrong\u003eOverview\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003eSLU-PP-322 (also referred to in published literature as SLU-PP-332) is a synthetic small molecule and pan-agonist of estrogen-related receptors (ERRα, ERRβ, ERRγ), nuclear receptors that regulate mitochondrial function, oxidative metabolism, and energy expenditure in metabolically active tissues including skeletal muscle, cardiac muscle, and adipose tissue. It is classified as an exercise mimetic compound and is currently investigational, with no FDA approval. Research has been conducted primarily at the University of Florida and Saint Louis University.\u003c\/p\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003e\u003cstrong\u003eMechanism of Action\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003eSLU-PP-322 activates ERRα (with approximately 4-fold selectivity over ERRγ), triggering an acute aerobic exercise-like gene expression program. This activation upregulates genes involved in mitochondrial biogenesis, fatty acid oxidation, oxidative phosphorylation, and skeletal muscle fiber type remodeling toward oxidative (Type IIa) fibers. The compound does not affect appetite, food intake, or hormonal axes.\u003c\/p\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003e\u003cstrong\u003eResearch Applications and Preclinical Findings\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003eIn diet-induced obese and ob\/ob mouse models, twice-daily administration for 28 days resulted in approximately 12% reduction in body weight and significantly attenuated fat mass accumulation. Normal-weight mice demonstrated up to 70% improvement in exercise endurance and 45% increase in running distance. Additional preclinical research suggests cardioprotective effects including improved cardiac ejection fraction, reduced fibrosis, and normalized fatty acid oxidation in heart failure models. Potential applications are being explored in metabolic syndrome, obesity, sarcopenia, muscular dystrophy, and age-related metabolic decline.\u003c\/p\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003e\u003cstrong\u003eAdministration\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003eCurrently administered via subcutaneous injection in research settings. Oral formulation development is ongoing. Not FDA-approved; human trials have not yet been reported.\u003c\/p\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003e\u003cstrong\u003ePotential Adverse Effects\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003eNo severe adverse effects reported in preclinical models to date. Potential mild effects include injection site irritation, fatigue, and headache. Long-term human safety data is absent.\u003c\/p\u003e","brand":"Aureon Bioscience","offers":[{"title":"Default Title","offer_id":46655977652382,"sku":null,"price":120.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0747\/1543\/1070\/files\/SLU-PP-322.jpg?v=1776914702"},{"product_id":"bpc-10mg-tb-10mg","title":"BPC-157 10MG + TB-500 10MG","description":"\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003e\u003cstrong\u003eOverview\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003eThe BPC-157\/TB-500 combination, sometimes referred to as the Wolverine Blend, pairs two distinct synthetic peptides studied for their complementary roles in tissue repair, angiogenesis, and recovery. BPC-157 is a synthetic 15-amino acid pentadecapeptide derived from a protein fragment found in human gastric juice. TB-500 is a synthetic analog of thymosin beta-4 (Tβ4), a naturally occurring actin-binding protein involved in cellular migration and tissue organization. Neither peptide is FDA-approved for human use; BPC-157 was classified as a Category 2 bulk drug substance by the FDA in 2023.\u003c\/p\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003e\u003cstrong\u003eMechanism of Action\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003eBPC-157 promotes local tissue healing by upregulating growth hormone receptors in fibroblasts, stimulating collagen synthesis, modulating angiogenesis via nitric oxide and VEGF pathways, and exerting anti-inflammatory effects on oxidative and cytokine signaling cascades. It also supports gastrointestinal mucosal integrity.\u003c\/p\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003eTB-500 operates systemically by promoting actin cytoskeletal reorganization, cell migration, and new blood vessel formation. As a thymosin beta-4 analog, it supports extracellular matrix remodeling, reduces fibrotic scarring, and enhances tissue elasticity and functional recovery.\u003c\/p\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003eWhen used in combination, BPC-157 tends to exert more localized effects at the injury site while TB-500 supports systemic recovery across multiple tissue types, creating a complementary healing response.\u003c\/p\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003e\u003cstrong\u003eResearch and Off-Label Applications\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003eMusculoskeletal injury repair (tendon, ligament, muscle), post-surgical recovery, chronic joint pain and inflammation, gut and mucosal healing (BPC-157), cardiovascular protection and cardiac recovery (TB-500), and anti-aging tissue regeneration.\u003c\/p\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003e\u003cstrong\u003eAdministration\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003eAdministered as two separate subcutaneous injections. Protocols commonly utilize 10 mg of each compound. Peak results are typically observed 4–8 weeks into therapy. Clinical protocols generally recommend limiting continuous use to 90 days followed by a 30-day washout period.\u003c\/p\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003e\u003cstrong\u003ePotential Adverse Effects\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003eGenerally well tolerated in available research. Potential concerns include theoretical promotion of angiogenesis in the context of undetected malignancy, mild injection site reactions, and fatigue. The combination should not be used in individuals with active cancer without specialist guidance. Long-term human safety data is limited.\u003c\/p\u003e","brand":"Aureon Bioscience","offers":[{"title":"Default Title","offer_id":46655979913374,"sku":null,"price":150.0,"currency_code":"USD","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0747\/1543\/1070\/files\/BPC_TB.jpg?v=1776914702"},{"product_id":"glutathione","title":"GLUTATHIONE 1500mg","description":"\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003e\u003cstrong\u003eOverview\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003eGlutathione (GSH) is a naturally occurring tripeptide composed of glutamine, glycine, and cysteine. It is synthesized endogenously in the liver and is present in virtually every cell of the human body. Glutathione is the primary intracellular antioxidant and serves as the foundation of the body's broader antioxidant network. Endogenous levels decline with age by approximately 30–50% between young adulthood and older age, and are further depleted by oxidative stress, chronic illness, toxin exposure, and poor nutrition.\u003c\/p\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003e\u003cstrong\u003eMechanism of Action\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003eGlutathione neutralizes free radicals and reactive oxygen species (ROS) by donating electrons via its sulfhydryl group. It regenerates oxidized vitamins C and E back to their active forms through the glutathione-ascorbate cycle, maintains the intracellular GSH\/GSSG redox ratio, supports phase-II hepatic detoxification pathways, and modulates immune signaling. It also inhibits tyrosinase activity, which influences melanin synthesis.\u003c\/p\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003e\u003cstrong\u003eResearch and Off-Label Applications\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003eCellular antioxidant defense and oxidative stress reduction, hepatic detoxification and liver support, skin brightening and pigmentation modulation, immune function enhancement, neuroprotection and potential role in neurodegenerative conditions, post-chemotherapy recovery support, and general anti-aging and longevity protocols.\u003c\/p\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003e\u003cstrong\u003eAdministration\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003eOral bioavailability is poor due to gastrointestinal degradation of the tripeptide. Clinically meaningful systemic elevation is most reliably achieved via intravenous (IV) infusion, intramuscular (IM), or subcutaneous injection. Plasma half-life of reduced GSH is approximately 14 minutes; cellular effects accumulate with consistent administration over 4–8 week cycles. Liposomal oral formulations offer improved but still variable bioavailability.\u003c\/p\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003e\u003cstrong\u003ePotential Adverse Effects\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003eGenerally well tolerated when administered appropriately. Serious adverse events include rare anaphylaxis and potential hepatotoxicity, particularly with intravenous use at non-standardized doses. Long-term use may reduce zinc levels. May worsen asthma in susceptible individuals if inhaled. Should not be used concurrently with chemotherapy without oncologist approval, as it may interfere with treatment efficacy. Quality and sterility of the source compound are critical safety considerations.\u003c\/p\u003e","brand":"Aureon Bioscience","offers":[{"title":"Default Title","offer_id":46655980306590,"sku":null,"price":150.0,"currency_code":"USD","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0747\/1543\/1070\/files\/GLUTATHIONE.jpg?v=1776914703"}],"url":"https:\/\/checkout.aureonbioscience.com\/collections\/frontpage.oembed","provider":"Aureon Bioscience","version":"1.0","type":"link"}